Pulmonale Hypertonie und Rechtsherzversagen auf der Intensivstation

di Meyer, F.J., Katus, H.A., Borst, M.M.
Pubblicato in Pneumologe (Berl) (2008)

The value of contrast dobutamine stress echocardiography in detecting coronary artery disease in overweight and obese patients

di Hu, Shen-Jiang, Liu, Sheng-Xiang, Katus, HA, Luedde, Mark
Pubblicazione 2007

Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid

di Jehle, J, Staudacher, I, Wiedmann, F, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Pubblicazione 2012

Gene therapy targets in Heart Failure: the Path to translation

di Raake, PWJ, Tscheschner, H, Reinkober, J, Ritterhoff, J, Katus, HA, Koch, WJ, Most, P
Pubblicazione 2011

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation

di Doesch AO, Mueller S, Akyol C, Erbel C, Frankenstein L, Ruhparwar A, Ehlermann P, Dengler TJ, Katus HA
Pubblicazione 2013-10-01

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

di Erbel C, Achenbach J, Akhavanpoor M, Dengler TJ, Lasitschka F, Gleissner CA, Bea F, Katus HA, Szabo G
Pubblicazione 2011-08-01

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

di Erbel, C, Achenbach, J, Akhavanpoor, M, Dengler, TJ, Lasitschka, F, Gleissner, CA, Bea, F, Katus, HA, Szabo, G
Pubblicazione 2011

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

di Kraeuter M, Helmschrott M, Erbel C, Gleissner CA, Frankenstein L, Schmack B, Ruhparwar A, Ehlermann P, Katus HA, Doesch AO
Pubblicazione 2013-11-01

TASK1 (K(2P)3.1) K(+) channel inhibition by endothelin-1 is mediated through Rho kinase-dependent phosphorylation

di Seyler, C, Duthil-Straub, E, Zitron, E, Gierten, J, Scholz, EP, Fink, RHA, Karle, CA, Becker, R, Katus, HA, Thomas, D
Pubblicazione 2012

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

di Helmschrott M, Beckendorf J, Akyol C, Ruhparwar A, Schmack B, Erbel C, Gleissner CA, Akhavanpoor M, Ehlermann P, Bruckner T, Katus HA, Doesch AO
Pubblicazione 2014-09-01

Proinflammatory and prothrombotic effects on human vascular endothelial cells of Immune-cell-derived LIGHT

di Celik S, Shankar V, Richter A, Hippe H-J, Akhavanpoor M, Bea F, Erbel C, Urban S, Blank N, Wambsganss N, Katus HA, Dengler TJ
Pubblicazione 2009-04-01

Rosuvastatin reduces neointima formation in a rat model of balloon injury

di Preusch, MR, Vanakaris, A, Bea, F, Ieronimakis, N, Shimizu, T, Konstandin, M, Morris-Rosenfeld, S, Albrecht, C, Kranzhöfer, A, Katus, HA, Blessing, E, Kranzhöfer, R
Pubblicazione 2010

Proinflammatory and prothrombotic effects on human vascular endothelial cells of Immune-cell-derived LIGHT

di Celik, S, Shankar, V, Richter, A, Hippe, H-J, Akhavanpoor, M, Bea, F, Erbel, C, Urban, S, Blank, N, Wambsganss, N, Katus, HA, Dengler, TJ
Pubblicazione 2009

A new system for quantitative determination of troponin T and myoglobin in the emergency room and in the intensive care unit

di Waldenhofer, U, Hirsch, MM, Laggner, AN, Katus, HA, Müller-Bardorff, M, Sylvén, C, Rasmanis, G, Collinson, PO, Gerhardt, W, Hafner, G, Zerback, R, Leinberger, R
Pubblicazione 1998

Mechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced p...

di Jehle, J, Ficker, E, Wan, X, Deschenes, I, Kisselbach, J, Wiedmann, F, Staudacher, I, Schmidt, C, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Pubblicazione 2013

Carvedilol targets human K(2P)3.1 (TASK1) K(+) leak channels

di Staudacher, K, Staudacher, I, Ficker, E, Seyler, C, Gierten, J, Kisselbach, J, Rahm, A-K, Trappe, K, Schweizer, PA, Becker, R, Katus, HA, Thomas, D
Pubblicazione 2011

Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model

di Weber, C, Neacsu, I, Krautz, B, Schlegel, P, Sauer, S, Raake, P, Ritterhoff, J, Jungmann, A, Remppis, AB, Stangassinger, M, Koch, WJ, Katus, HA, Müller, OJ, Most, P, Pleger, ST
Pubblicazione 2013